Variant report
Variant | nsv969225 |
---|---|
Chromosome Location | chr5:59519253-59524138 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182282335 | chr5:59519312-59519313 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs533508703 | chr5:59519323-59519324 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553372384 | chr5:59519409-59519410 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567176693 | chr5:59519417-59519418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536528660 | chr5:59519424-59519425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549253388 | chr5:59519445-59519446 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187438889 | chr5:59519515-59519516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544881750 | chr5:59519543-59519544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375224766 | chr5:59519544-59519545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192723754 | chr5:59519704-59519705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541410037 | chr5:59519753-59519754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146521336 | chr5:59519780-59519781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530073709 | chr5:59519786-59519787 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544092397 | chr5:59519801-59519802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183696504 | chr5:59519806-59519807 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563830184 | chr5:59519809-59519810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs532698403 | chr5:59519813-59519814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552367978 | chr5:59519856-59519857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115833185 | chr5:59519867-59519868 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112999073 | chr5:59519868-59519869 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs547122492 | chr5:59519916-59519917 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370043186 | chr5:59519925-59519926 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs140976033 | chr5:59520038-59520039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535917746 | chr5:59520043-59520044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550468193 | chr5:59520047-59520048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs560174589 | chr5:59520074-59520075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556378456 | chr5:59520079-59520080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374093207 | chr5:59520114-59520115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150140503 | chr5:59520135-59520136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538804778 | chr5:59520256-59520257 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558810226 | chr5:59520264-59520265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs117476781 | chr5:59520292-59520293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541522625 | chr5:59520303-59520304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554806386 | chr5:59520311-59520312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574728839 | chr5:59520385-59520386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs543462079 | chr5:59520427-59520428 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7442640 | chr5:59520445-59520446 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
38 | rs60487676 | chr5:59520494-59520495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs551360052 | chr5:59520574-59520575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148860412 | chr5:59520599-59520600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs143445086 | chr5:59520606-59520607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369963572 | chr5:59520628-59520629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547083836 | chr5:59520661-59520662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560825593 | chr5:59520686-59520687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529653565 | chr5:59520687-59520688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76829110 | chr5:59520772-59520773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs564458294 | chr5:59520788-59520789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569906760 | chr5:59520823-59520824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538913540 | chr5:59520827-59520828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs552534883 | chr5:59520901-59520902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:59506800-59528000 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr5:59516000-59519400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr5:59518800-59519600 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr5:59518800-59520000 | Enhancers | Hela-S3 | cervix |
5 | chr5:59519400-59520000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr5:59520000-59525200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr5:59522400-59523600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
8 | chr5:59523600-59524000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr5:59524000-59525800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |